1. Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection. (4th July 2022) Authors: Bavaro, DF; Diella, L; Solimando, AG; Cicco, S; Buonamico, E; Stasi, C; Ciannarella, M; Marrone, M; Carpagnano, F; Resta, O; Carpagnano, GE; Palmieri, VO; Vacca, A; Dell'Aera, M; Dell'Erba, A; Migliore, G; Aricò, M; Saracino, A Journal: Pathogens and global health Issue: Volume 116:Number 5(2022) Page Start: 297 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Prioritizing Genomic Applications for Action by Level of Evidence: A Horizon‐Scanning Method. Issue 4 (19th February 2014) Authors: Dotson, W D; Douglas, M P; Kolor, K; Stewart, A C; Bowen, M S; Gwinn, M; Wulf, A; Anders, H M; Chang, C Q; Clyne, M; Lam, T K; Schully, S D; Marrone, M; Feero, W G; Khoury, M J Journal: Clinical pharmacology & therapeutics Issue: Volume 95:Issue 4(2014) Page Start: 394 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗